Clinical Trial Update: Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AMT-101 in ulcerative colitis; efficacy and safety data are not specified in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• AMT-101

Snippet

Sponsor: Applied Molecular Transport | Conditions: Ulcerative Colitis | Phase 2 | Status: UNKNOWN